Correlation Between Predictive Oncology and Innerscope Advertising

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and Innerscope Advertising at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and Innerscope Advertising into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Predictive Oncology and Innerscope Advertising Agency, you can compare the effects of market volatilities on Predictive Oncology and Innerscope Advertising and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of Innerscope Advertising. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and Innerscope Advertising.

Diversification Opportunities for Predictive Oncology and Innerscope Advertising

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Predictive and Innerscope is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and Innerscope Advertising Agency in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innerscope Advertising and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with Innerscope Advertising. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innerscope Advertising has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and Innerscope Advertising go up and down completely randomly.

Pair Corralation between Predictive Oncology and Innerscope Advertising

Given the investment horizon of 90 days Predictive Oncology is expected to generate 12.3 times less return on investment than Innerscope Advertising. But when comparing it to its historical volatility, Predictive Oncology is 3.51 times less risky than Innerscope Advertising. It trades about 0.01 of its potential returns per unit of risk. Innerscope Advertising Agency is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.38  in Innerscope Advertising Agency on May 28, 2025 and sell it today you would lose (0.09) from holding Innerscope Advertising Agency or give up 23.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.41%
ValuesDaily Returns

Predictive Oncology  vs.  Innerscope Advertising Agency

 Performance 
       Timeline  
Predictive Oncology 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Predictive Oncology is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Innerscope Advertising 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Innerscope Advertising Agency are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Innerscope Advertising exhibited solid returns over the last few months and may actually be approaching a breakup point.

Predictive Oncology and Innerscope Advertising Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Predictive Oncology and Innerscope Advertising

The main advantage of trading using opposite Predictive Oncology and Innerscope Advertising positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, Innerscope Advertising can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innerscope Advertising will offset losses from the drop in Innerscope Advertising's long position.
The idea behind Predictive Oncology and Innerscope Advertising Agency pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets